Immunohistochemical Markers in Endometrial Cancer

Immunohistochemical Markers in Endometrial Cancer

In 2018, 382,069 new cases of uterine cancer were registered worldwide and 89,929 deaths from this cancer were reported [...]

Bibliographic Details
Main Authors:	Valerio Mais, Michele Peiretti
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Cancers
Subjects:	n/a
Online Access:	https://www.mdpi.com/2072-6694/13/3/505

Similar Items

Targeting Wnt Signaling in Endometrial Cancer
by: Iram Fatima, et al.
Published: (2021-05-01)

Immunohistochemical Expression
by: Carla Loreto, et al.
Published: (2021-01-01)

Expression of neuroendocrine markers in endometrial carcinomas — an immunohistochemical analysis
by: Witold Kędzia, et al.
Published: (2012-07-01)

Introduction to the Special Issue: In Vitro Digestibility in Animal Nutritional Studies
by: Pier Giorgio Peiretti
Published: (2020-05-01)

Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers
by: Jiang P, et al.
Published: (2020-08-01)

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma
by: Amany Salama, et al.
Published: (2019-05-01)

A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers
by: Vit Weinberger, et al.
Published: (2019-04-01)

Correction: Moeker, N.; et al. Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings. Antibodies 2017, 6, 15
by: Nina Möker, et al.
Published: (2018-08-01)

New Prognostic and Predictive Markers in Cancer Progression
by: Susan Costantini, et al.
Published: (2020-11-01)

Addendum: Manabu, K., et al. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer. <i>Cancers</i> 2020, <i>12</i>, 2748
by: Manabu Kojima, et al.
Published: (2021-02-01)

A Nomogram Model Involving Immunohistochemical Markers for Predicting the Recurrence of Stage I-II Endometrial Cancer
by: Peng Jiang, et al.
Published: (2021-01-01)

The Improvement of Laparoscopic Surgical Skills Obtained by Gynecologists after Ten Years of Clinical Training Can Reduce Peritoneal Adhesion Formation during Laparoscopic Myomectomy: A Retrospective Cohort Study
by: Valerio Mais, et al.
Published: (2017-01-01)

Immunohistochemical studies of human endometrial stroma
by: Marshall, Robert John
Published: (1990)

An immunohistochemical study of endometrial hyperplasia and neoplasia
by: Sivridis, E.
Published: (1986)

Imaging and Biochemical Markers for Osteoarthritis
by: Benny Antony, et al.
Published: (2021-07-01)

Stem and Cancer Stem Cell Identities, Cellular Markers, Niche Environment and Response to Treatments to Unravel New Therapeutic Targets
by: Jose R. Pineda, et al.
Published: (2021-01-01)

Immunohistochemical and Molecular Characterization of Endometrial Stromal Sarcomas
by: Sneha Subbaraya, et al.
Published: (2020-05-01)

Erratum: Rupprecht, C.E., et al. Additional Progress in the Development and Application of a Direct, Rapid Immunohistochemical Test for Rabies Diagnosis. Vet. Sci. 2018, 5, 59
by: Charles E. Rupprecht, et al.
Published: (2018-07-01)

Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8
by: Ana I. Hernandez-Caballero, et al.
Published: (2020-08-01)

Comparison of immunohistochemical characteristics of prognostic markers expression in non-metastatic and metastatic invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2016-10-01)

Mentally Sick or Not—(Bio)Markers of Psychiatric Disorders Needed
by: Napoleon Waszkiewicz
Published: (2020-07-01)

Genetic Diversity Assessment and Marker-Assisted Selection in Crops
by: Francesco Mercati, et al.
Published: (2020-12-01)

The prognostic significance of the immunohistochemical expression of P53 and BCL-2 in endometrial cancer
by: Lech Chyczewski, et al.
Published: (2012-01-01)

Molecular, immunohistochemical and biophysical assessment of myometrial invasion in stage I endometrial cancer
by: Alexander-Sefre, Farhad
Published: (2006)

Comment on “Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer” <i>Cancers</i> 2019, <i>11</i>, 596: Markers for Early Detection of Ovarian Cancer
by: Gil Mor, et al.
Published: (2019-09-01)

Histological and immunohistochemical evaluation of leiomyoma and endometrial tissue in patients with uterine leiomyoma and endometrial hyperplasia
by: Potapov V.A., et al.
Published: (2014-03-01)

Reply to Comment on “Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer” <i>Cancers</i> 2019, <i>11</i>, 596: Markers for Early Detection of Ovarian Cancer
by: Jing Guo, et al.
Published: (2019-09-01)

New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies
by: Karolina Woziwodzka, et al.
Published: (2020-05-01)

Correction: Shen, J.; et al. Biological Aging Marker p16<sup>INK4a</sup> in T Cells and Breast Cancer Risk. <i>Cancers</i> 2020, <i>12</i>, 3122
by: Jie Shen, et al.
Published: (2021-01-01)

Immunohistochemical features of benign endometrial hyperplasia in premenopausal women
by: Н. М. Рожковська, et al.
Published: (2020-10-01)

The significance of markers in the diagnosis of endometrial cancer
by: Monika M. Żyła, et al.
Published: (2016-11-01)

Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer
by: Lin Deng, et al.
Published: (2020-02-01)

Immunohistochemical Study of ER, PR, Ki67 and p53 in Endometrial Hyperplasias and Endometrial Carcinomas
by: Nayar Musfera Abdul Masjeed, et al.
Published: (2017-08-01)

Erratum: Shibata S.; et al. Proton Beam Therapy without Fiducial Markers Using Four-Dimensional CT Planning for Large Hepatocellular Carcinomas. <em>Cancers</em> 2018, <em>10</em>, 71
by: Satoshi Shibata, et al.
Published: (2018-12-01)

Review of Certainty and Doubt in Academic Discourse: Epistemic Modality Markers in English and Polish Linguistics Articles
by: Mercedes Querol Julián
Published: (2018-11-01)

BETA-CATENIN – AN IMPORTANT IMMUNOHISTOCHEMICAL TOOL IN STRATIFYING ENDOMETRIAL CARCINOMAS?
by: Anca EVSEI, et al.
Published: (2021-06-01)

Immunohistochemical expression of PTEN in normal, hyperplastic and endometrial carcinoma of endometrium
by: IzadiMood, et al.
Published: (2008-08-01)

Special Issue: Advances in Computational Electromagnetics
by: Valerio De Santis
Published: (2021-06-01)

Molecular markers of endometrial cancer (review of literature)
by: N. E. Levchenko, et al.
Published: (2014-07-01)

Significance Of Immunohistochemical Markers In Diagnostics Of Urinary Bladder Cancer
by: A.V. Medvedeva, et al.
Published: (2009-12-01)

Cannot write session to /tmp/vufind_sessions/sess_phu3bormptge91uhf7hki5s95q